Three recent papers (by Roessner et al. [[12][1]], Kajiwara et al. [[5][2]], and Santander et al. [[14][3]]) report the use of a combination of genetic engineering, enzymology, bio-organic chemistry, and high-resolution NMR spectroscopy to help fine-tune what is known of the anaerobic pathway to
No takes yet. Share an insight, caveat, or question.
Roessner et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: